Drugdu.com expert’s response: In medical device foreign trade communication, many buyers do not ask for prices right away. Instead, they frequently raise questions like: “Can this product be imported into our country?” or “Do you have documents for our market?” Quite a few suppliers simply reply: “Yes, we can export.” This statement is not incorrect, but it fails to provide sufficient information for buyers. When a buyer asks “whether the product can be imported”, they do not merely want to confirm if the supplier has export experience. What they care more about are potential issues the product may encounter when entering the local market, including registration, certification, customs clearance, labeling, instructions for use, after-sales services and other related aspects. If a supplier only replies “we can export”, the buyer will have to ask numerous follow-up questions. Once the communication process becomes overly lengthy, the buyer is very likely to turn to other suppliers ...
Organiser:Weilian Exhibitions Time:August 8th – 9th, 2026 Address:East End of East University Street, Hohhot, Inner Mongolia Autonomous Region Exhibition hall: Inner Mongolia International Convention and Exhibition Center Product range: Pharmaceuticals, health supplements, medical supplies, medical devices, adult products, beauty and personal care products, home medical rehabilitation products, epidemic prevention materials, maternal and infant products, equipment and packaging About Inner Mongolia Pharmaceutical Fair: Inner Mongolia Pharmaceutical Fair & Inner Mongolia Medical Device Exhibition (referred to as “Inner Mongolia Pharmaceutical Fair”) is a well-known domestic trade fair for pharmaceuticals and health products. Founded in 1999, it is known as the “barometer of the national pharmaceutical and health product industry”, “China’s No.1 fixed-city pharmaceutical exhibition”, and has ranked as the largest fixed-city exhibition in China for ten consecutive years. As one of the oldest and largest branded industry events in China’s pharmaceutical sector, it covers all links of medical R&D, production, operation ...
Drugdu.com expert’s response: Under the EU MDR, the quality management system requirements for manufacturers are not limited to “production process compliance.” Manufacturers are expected to establish a quality management system that covers the full lifecycle of medical devices. In simple terms, the QMS should demonstrate that the product remains under continuous control from design and development, production and release, through to post-market feedback and risk control. The key requirements can be summarized in five areas: 1. Establish a quality management system that meets MDR requirements Manufacturers need to establish, implement, maintain and continuously improve their QMS. The system should cover processes such as product design and development, production, inspection, release, supplier management, document control, change control, nonconforming product handling, CAPA, internal audits and management review. 2. Include regulatory compliance in the QMS The QMS should clearly define product classification, conformity assessment routes, applicable standards, evidence of compliance with the General ...
Organiser:KRISTA EXHIBITIONS Time: August 5th – 7th, 2026 Address:Jl. Gatot Subroto No.1, RT.1/RW.3, Gelora, Kecamatan Tanah Abang, Kota Jakarta Pusat, Daerah Khusus Ibukota Jakarta 10270, Indonesia Exhibition hall:Balai Sidang Jakarta Convention Center Product range: Medical Devices: Diagnostic medical equipment, traditional Oriental medicine therapies & equipment, dental instruments, clinic examination apparatus, obesity treatment and healthcare equipment, ophthalmic medical instruments Rehabilitation Equipment: Surgical instruments & equipment, therapeutic apparatus & equipment, radiological medical equipment, hospital facilities and emergency equipment, central supply equipment, Asian medicine & related devices, rehabilitation healthcare supplies, disposable instruments, other medical-related products Medical Supplies: Ward nursing equipment and appliances (beds, trolleys, tables, cabinets, racks, etc.); Disinfection products (medical air sterilizers, vacuum sterilizers, ultrasonic cleaning systems, disinfectants, etc.); Auxiliary products (oxygen generators, ventilators, sphygmomanometers, blood glucose meters, thermometers, potential therapy devices, radiation protection supplies, oxygen generation & supply equipment, blood bank facilities, medical data & image processing equipment, rehabilitation devices, special ...
Drugdu.com expert’s response: Medical devices are classified and managed into three categories in ascending order of risk level, with the Rules for the Classification of Medical Devices as the core basis. 1. Management Classification of Three Categories of Medical Devices Class I: Medical devices with low risk, whose safety and effectiveness can be ensured through routine management, such as ordinary medical surgical masks and medical examination gloves. Class II: Medical devices with moderate risk that require strict control and management to ensure safety and effectiveness, such as clinical thermometers and non-invasive monitors. Class III: Medical devices with relatively high risk that need particularly strict control measures to ensure safety and effectiveness, such as implantable cardiac pacemakers and artificial joints. 2. Supporting Classification Management Rules In addition to the risk classification of the products themselves, China also implements classified and hierarchical supervision for the production and operation links, clarifying the responsibilities of regulatory ...
Drugdu.com expert’s response: Recently, some suppliers have raised a very practical question: “My products already have views. Why are there still no buyer inquiries?” This is quite common for medical device products. When medical device buyers browse products on a platform, they usually do not send an inquiry immediately after seeing one product. They first make a judgment: Is this the product I am looking for? Is this company reliable? Can the certificates and documents support my target market? Will communication with this supplier be complicated? So, having views does not mean inquiries will come right away. Views show that the product has received a certain level of exposure. But whether buyers are willing to make further contact depends on whether the product page and company information can support their sourcing decision. 1. Buyers saw the product, but did not see a clear reason to contact you For many product ...
Organiser:Beijing Life Science and Technology Industry Association, Shanghai Biomedical Industry Association Time:July 16–18, 2026 Address:Fuhua 3rd Road, Futian District, Shenzhen Exhibition hall:Shenzhen Futian Convention & Exhibition Center Product range: Antibody drugs, stem cells and regenerative medicine, immune cell therapy, cell-based drugs, 3D cell culture, cellular multi-omics, organoids, exosomes, target screening, pharmaceutical innovation, novel vaccines, gene therapy, oncolytic viruses, etc. About CBIC: The China Cell Biology Industry Conference (CBIC) and Biomedical Innovation Cooperation Conference will cover core topics including antibody drugs, stem cells and regenerative medicine, immune cell therapy, cell-based drugs, 3D cell culture, cellular multi-omics, organoids, exosomes, target screening, pharmaceutical innovation, novel vaccines, gene therapy, and oncolytic viruses. The conferences will focus on cutting-edge biotech advances, clinical applications, industrialization processes, investment and financing opportunities, industry standardization, and emerging regulatory trends. The biomedical industry is one of China’s key strategic emerging industries. Currently, China is the world’s second-largest pharmaceutical ...
Originally produced by Yang Xixia, Jianshi Bureau, July 14, 2026 20:24 Beijing On July 14, China’s innovative drug industry saw another major deal: ج Dizal Pharma willgrant AstraZeneca the exclusive global development and commercialization rights to suvolotinib. AstraZeneca will pay Dizal Pharma a $600 million upfront payment and $900 million in milestone payments, with clinical development and sales milestones capped at $400 million and $500 million, respectively. Simply put, AstraZenecabought out suvolotinib outright for $1.5 billion. As soon as the news broke, Dizal Pharma’s stock surged 20CM in the afternoon. The capital market recognized the certainty of this deal. Unlike other BD deals that often run into the billions of dollars, Dizhe’s $1.5 billion total may not be large, but the $600 million upfront payment is real cash in hand, and the future milestone payments are also highly certain. This is the fundamental reason the market is willing to pay ...
Organiser:Medical Association of Bogotá Chamber of Commerce, Messe Düsseldorf GmbH Time:July 28th – July 31st, 2026 Address:CORFERIAS Bogotá – Colombia Todos los derechos reservados, Carrera 37 No 24 – 67 Conmutador Exhibition hall:Corferias Bogota Product range: Medical Instruments and Equipment: Surgical instruments, surgical orthopedic supplies, orthopedic products, diagnostic equipment, monitoring equipment, therapeutic equipment, disinfection and sterilization equipment, preventive medical equipment, ophthalmic instruments and equipment, otolaryngological equipment, radiological medical equipment, rehabilitation physiotherapy equipment, traction and correction equipment, prosthetics and rehabilitation devices, medical vehicles, beds and tables, first-aid and ambulance equipment, medical auxiliary equipment, etc. Medical Institutions and Laboratory Technical Equipment: Laboratory instruments and equipment, laboratory furniture, laboratory automation and accessories, optical instruments and equipment, medical experimental analysis and diagnostic instruments, biotechnology equipment, etc. Medical Materials: Disposable medical consumables, surgical hygiene products, dressings, wound care materials, catheters, interventional materials, first-aid kits, first-aid packs, other medical materials, etc. Healthcare Products: Medical electronic ...
Go to Page Go
your submission has already been received.
OK
Please enter a valid Email address!
Submit
The most relevant industry news & insight will be sent to you every two weeks.